PBH
NYSEPrestige Consumer Healthcare Inc.
News · 26 weeks36-96%
2025-12-142026-06-07
Mix2890d
- Insider19(68%)
- Earnings3(11%)
- SEC Filings3(11%)
- Other2(7%)
- Analyst1(4%)
Latest news
25 items- PRPrestige Consumer Healthcare Inc. to Participate in the Oppenheimer Annual Consumer Growth and E-Commerce ConferenceTARRYTOWN, N.Y., June 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in a fireside chat at the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference virtually on Monday, June 8, 2026 at 9:45 a.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors" section and the "Events and Presentations" tab, or by using the following link: https://ir.prestigebrands.com/events-presentations/events For those unable to participate during the live webcast, a replay option will be available on the Company's website following the event. About Prestige Consumer Healthcar
- SECSEC Form 10-K filed by Prestige Consumer Healthcare Inc.10-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- INSIDERAmendment: CFO & COO Sacco Christine covered exercise/tax liability with 1,091 shares, decreasing direct ownership by 2% to 57,374 units (SEC Form 4)4/A - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- ANALYSTPrestige Consumer downgraded by OppenheimerOppenheimer downgraded Prestige Consumer from Outperform to Perform
- SECPrestige Consumer Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- PRPrestige Consumer Healthcare Inc. Reports Fiscal 2026 Results, Announces Acquisition of LaCorium HealthReported revenues of $281.6 million in Q4 and $1,088.7 million in fiscal year 2026Diluted EPS of $3.91 and Adjusted Diluted EPS of $4.38 in fiscal year 2026Announces agreement to acquire LaCorium Health, a leader in Australian therapeutic skin careIntroducing Outlook for Fiscal 2027 Organic Revenue Growth and Adjusted Diluted EPS of 1% to 3%, respectively, excluding the impact of acquisitions TARRYTOWN, N.Y., May 13, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2026. "Our fiscal 2026 demonstrated the resilience of our business model in a challenging consumer backdrop. Our div
- INSIDERSenior VP Operations Zerillo Jeffrey sold $18,350 worth of shares (351 units at $52.28), decreasing direct ownership by 0.83% to 41,810 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERSenior VP Operations Zerillo Jeffrey sold $16,580 worth of shares (305 units at $54.36) and covered exercise/tax liability with 351 shares, decreasing direct ownership by 2% to 42,161 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERCFO & COO Sacco Christine covered exercise/tax liability with 991 shares, decreasing direct ownership by 1% to 71,636 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERChief Executive Officer Lombardi Ronald M. covered exercise/tax liability with 2,543 shares, decreasing direct ownership by 0.68% to 373,465 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDEREVP, Marketing & Sales Mekhail Adel covered exercise/tax liability with 487 shares, decreasing direct ownership by 2% to 25,703 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERSenior VP Operations Zerillo Jeffrey covered exercise/tax liability with 307 shares and sold $66,373 worth of shares (1,207 units at $54.99), decreasing direct ownership by 3% to 42,820 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERCFO & COO Sacco Christine covered exercise/tax liability with 1,267 shares, decreasing direct ownership by 2% to 72,627 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERChief Executive Officer Lombardi Ronald M. covered exercise/tax liability with 2,197 shares, decreasing direct ownership by 0.58% to 376,008 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERCFO & COO Sacco Christine was granted 18,984 shares and covered exercise/tax liability with 3,434 shares, increasing direct ownership by 27% to 73,894 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDEROfficer P'Pool William was granted 7,862 shares and covered exercise/tax liability with 1,888 shares, increasing direct ownership by 27% to 28,149 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERSenior VP Operations Zerillo Jeffrey was granted 5,307 shares, covered exercise/tax liability with 1,243 shares and sold $19,141 worth of shares (346 units at $55.32), increasing direct ownership by 9% to 44,334 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDEREVP, Marketing & Sales Mekhail Adel was granted 7,519 shares and covered exercise/tax liability with 1,695 shares, increasing direct ownership by 29% to 26,190 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERChief Executive Officer Lombardi Ronald M. was granted 51,130 shares and covered exercise/tax liability with 16,789 shares, increasing direct ownership by 10% to 378,205 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERCFO & COO Sacco Christine covered exercise/tax liability with 1,091 shares, decreasing direct ownership by 2% to 58,344 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERSenior VP Operations Zerillo Jeffrey covered exercise/tax liability with 432 shares, decreasing direct ownership by 1% to 40,616 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERChief Executive Officer Lombardi Ronald M. covered exercise/tax liability with 2,665 shares, decreasing direct ownership by 0.77% to 343,864 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDEREVP, Marketing & Sales Mekhail Adel covered exercise/tax liability with 542 shares, decreasing direct ownership by 3% to 20,366 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDEROfficer P'Pool William covered exercise/tax liability with 599 shares, decreasing direct ownership by 3% to 22,175 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- PRPrestige Consumer Healthcare to Release Fiscal 2026 Fourth Quarter and Year-End Earnings ResultsTARRYTOWN, N.Y., April 30, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 fourth quarter and year-end earnings release on Wednesday, May 13, 2026 after the market close. The following morning, May 14, at 8:30 a.m. ET, the Company will host a conference call to discuss the results. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to joi
PBH FAQ
7 questionsWhat does Prestige Consumer Healthcare Inc. do?
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief...Where does PBH stock trade?
Prestige Consumer Healthcare Inc. (PBH) is listed on NYSE.What sector and industry is PBH in?
Prestige Consumer Healthcare Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Prestige Consumer Healthcare Inc. go public?
Prestige Consumer Healthcare Inc. (PBH) completed its IPO in 2005.What are analysts saying about PBH?
Prestige Consumer Healthcare Inc. has had 8 recent analyst actions on file. The most recent action was from Oppenheimer: Perform on 2026-05-14.What companies are similar to PBH?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare PBH side-by-side with any of them on Quantisnow.How can I track PBH on Quantisnow?
Quantisnow aggregates Prestige Consumer Healthcare Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PBH to receive live email and push alerts on every new disclosure.